Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 85 Records) |
| Query Trace: Neoplasms and CYP2C9[original query] |
|---|
| Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1. Journal of clinical pharmacology 2016 May . Powers Jennifer L, Buys Saundra S, Fletcher Deborah, Melis Roberta, Johnson-Davis Kamisha, Lyon Elaine, Malmberg Elisabeth M, McMillin Gwendolyn |
| Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment. Pharmacogenetics and genomics 2017 9 27 (11): 402-409. Marcath Lauren A, Deal Allison M, Van Wieren Emily, Danko William, Walko Christine M, Ibrahim Joseph G, Weck Karen E, Jones David R, Desta Zeruesenay, McLeod Howard L, Carey Lisa A, Irvin William J, Hertz Daniel |
| Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). British journal of cancer 2017 Aug . Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet |
| Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy. Oncology letters 2018 Oct 16 (4): 4489-4497. Feng Wanjing, Liu Xin, Zhao Xiaoying, Huang Mingzhu, Guo Weijian, Yin Jiliang, Chen Zhiyu, Zhu Xiaodo |
| The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production. Cancer research 2018 7 78 (17): 4865-4877. Sausville Lindsay N, Gangadhariah Mahesha H, Chiusa Manuel, Mei Shaojun, Wei Shouzuo, Zent Roy, Luther James M, Shuey Megan M, Capdevila Jorge H, Falck John R, Guengerich F Peter, Williams Scott M, Pozzi Amb |
| Frequencies of poor metabolizer alleles of 12 pharmacogenomic actionable genes in Punjabi Sikhs of Indian Origin. Scientific reports 2018 Oct 8 (1): 15742. Sanghera Dharambir K, Bejar Cynthia, Sapkota Bishwa, Wander Gurpreet S, Ralhan Sar |
| Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC medical genetics 2019 Sep 20 (1): 148. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
| CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 2019 9 11 (9): . Ahmed Jemal Hussien, Makonnen Eyasu, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Aklillu Ele |
| CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
| Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer. Drug metabolism and disposition: the biological fate of chemicals 2020 6 48 (9): 796-803. Turner P Kellie, Hall Stephen D, Chapman Sonya C, Rehmel Jessica L, Royalty Jane E, Guo Yingying, Kulanthaivel Palaniapp |
| The point mutation analysis of Cyp2C9 (Arg144Cys C>T), Cyp2C9 (Ile359Leu A>C) and VKORC1 (1639G>A) in women with cervical cancer related to HPV: A case-control study. Journal of cellular physiology 2020 5 235 (12): 9317-9322. Golshekan Elham, Sohrabi Am |
| Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2020 5 11 406. Ahmed Jemal Hussien, Makonnen Eyasu, Bisaso Ronald Kuteesa, Mukonzo Jackson Kijumba, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Hassan Moustapha, Aklillu Ele |
| Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina. Arhiv za higijenu rada i toksikologiju 2021 6 72 (3): 129-134. Vidovi? Stojko, Škrbi? Ranko, Stojiljkovi? Miloš P, Vidovi? Vanja, Be?arevi? Jelena, Stoisavljevi?-Šatara Svjetlana, Maksimovi? Ne |
| Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma. Journal of clinical and translational hepatology 2021 Apr 9 (2): 169-179. Huo Junyu, Wu Liqun, Zang Yunj |
| Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
| Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2021 14 279-286. Jeiziner Chiara, Stäuble Céline K, Lampert Markus L, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
| Pharmacogenomic analysis of a genetically distinct Indigenous population. The pharmacogenomics journal 2021 11 22 (2): 100-108. Jaya Shankar Arvind, Jadhao Sudhir, Hoy Wendy, Foote Simon J, Patel Hardip R, Scaria Vinod, McMorran Brendan J, Nagaraj Shivashankar |
| Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. European journal of clinical pharmacology 2021 1 77 (8): 1095-1111. Wang Tingyu, Zhou Yitian, Cao Guoshe |
| Evaluating the Association of Genetic Polymorphism of Cytochrome p450 (CYP2C9*3) in Gastric Cancer Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Cureus 2022 Jul 14 (7): e27220. Uthansingh Kanishka, Parida Prasanta K, Pati Girish K, Sahu Manoj K, Padhy Rabindra |
| Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects. Advances in pharmacology (San Diego, Calif.) 2022 8 95 49-72. Daly Ann |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 May . Hwang Mary, Medley Sarah, Shakeel Faisal, Vanderwerff Brett, Zawistowski Matthew, Kidwell Kelley M, Hertz Daniel |
| Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer. Current cancer drug targets 2022 11 . Zhang Chan, Li Qi, Cheng Yujing, Yang Xin, Chen Wanlu, He Kunhua, Chen Mingw |
| Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer 2022 1 128 (8): 1649-1657. Reizine Natalie M, Danahey Keith, Truong Tien M, George David, House Larry K, Karrison Theodore G, van Wijk Xander M R, Yeo Kiang-Teck J, Ratain Mark J, O'Donnell Peter |
| G-quadruplex forming sequences in the genes coding for cytochrome P450 enzymes and their potential roles in drug metabolism. Biochimie 2023 9 . Mona Saad, Rongxin Zhang, Anne Cucchiarini, Cybel Mehawej, Jean-Louis Mergny, Mohamad Mroueh, Wissam H Fao |
| null. Drug metabolism and disposition: the biological fate of chemicals 2023 9 . Youhao Chen, Yaobin Lin, Shaoxing Guan, Zerui Zhao, Daren Lin, Jin Guan, Chengzhi Zhou, Junling Liu, Xiaolong Cao, Zhichao Lin, Diyao Chen, Jianbiao Shang, Weijian Zhang, Huohui Chen, Likun Chen, Shudong Ma, Lijia Gu, Jian Zhao, Min Huang, Xueding Wang, Hao Lo |
| Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
| Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
| CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
| The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 6 25 (6): 1977-1986. Rashmi A Gudur, Suresh J Bhosale, Anand K Gudur, Shivani R Kale, Ashwini L More, Kailas D Datkhi |
- Page last reviewed:Feb 1, 2024
- Content source: